Structural and Functional Similarity between the Bacterial Type III Secretion System Needle Protein PrgI and the Eukaryotic Apoptosis Bcl-2 Proteins

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Shortridge, Matthew D ^a   Powers, Robert ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BENZOPHENANTHRIDINE DERIVATIVE; CARRIER PROTEIN; CHELERYTHRINE; PROTEIN BCL 2; PROTEIN BCL X;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BIOLOGY; CHEMISTRY; COMPUTER PROGRAM; ENZYME ACTIVE SITE; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROTEIN BINDING; SALMONELLA TYPHIMURIUM; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; APOPTOSIS; BACTERIAL PROTEINS; BCL-X PROTEIN; BENZOPHENANTHRIDINES; CARRIER PROTEINS; CATALYTIC DOMAIN; COMPUTATIONAL BIOLOGY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; SALMONELLA TYPHIMURIUM; SEQUENCE HOMOLOGY, AMINO ACID; SOFTWARE;

EID: 77949324326     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007442     Document Type: Article

References (80)

1. Gerlt JA, Babbitt PC, (2001) Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies. Annu Rev Biochem 70: 209-246.
2. Mirny LA, Shakhnovich EI, (1999) Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. J Mol Biol 291: 177-196.
3. Park K, Kim D, (2008) Binding similarity network of ligand. Proteins 71: 960-971.
4. Campbell SJ, Gold ND, Jackson RM, Westhead DR, (2003) Ligand binding: functional site location, similarity and docking. Curr Opin Struct Biol 13: 389-395.
5. Powers R, Mercier KA, Copeland JC, (2008) The application of FAST-NMR for the identification of novel drug discovery targets. Drug Discov Today 13: 172-179.
6. Mercier KA, Baran M, Ramanathan V, Revesz P, Xiao R, et al.(2006) FAST-NMR: functional annotation screening technology using NMR spectroscopy. J Am Chem Soc 128: 15292-15299.
7. Powers R, (2007) Functional genomics and NMR spectroscopy. Comb Chem High Throughput Screen 10: 676-697.
8. Powers R, Copeland JC, Germer K, Mercier KA, Ramanathan V, et al.(2006) Comparison of protein active site structures for functional annotation of proteins and drug design. Proteins 65: 124-135.
9. Cornelis GR, Van Gijsegem F, (2000) Assembly and function of type III secretory systems. Annu Rev Microbiol 54: 735-774.
10. Kimbrough TG, Miller SI, (2002) Assembly of the type III secretion needle complex of Salmonella typhimurium. Microbes Infect 4: 75-82.
11. Macnab RM, (2003) How bacteria assemble flagella. Annu Rev Microbiol 57: 77-100.
12. Galan JE, (2001) Salmonella interactions with host cells: type III secretion at work. Annu Rev Cell Dev Biol 17: 53-86.
13. Grassme H, Jendrossek V, Gulbins E, (2001) Molecular mechanisms of bacteria induced apoptosis. Apoptosis 6: 441-445.
14. Yan N, Shi Y, (2005) Mechanisms of apoptosis through structural biology. Annu Rev Cell Dev Biol 21: 35-56.
15. Wang Y, Ouellette AN, Egan CW, Rathinavelan T, Im W, et al.(2007) Differences in the electrostatic surfaces of the type III secretion needle proteins PrgI, BsaL, and MxiH. J Mol Biol 371: 1304-1314.
16. Deane JE, Roversi P, Cordes FS, Johnson S, Kenjale R, et al.(2006) Molecular model of a type III secretion system needle: Implications for host-cell sensing. Proc Natl Acad Sci U S A103: 12529-12533.
17. Torruellas J, Jackson MW, Pennock JW, Plano GV, (2005) The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion. Mol Microbiol 57: 1719-1733.
18. Dietmann S, Park J, Notredame C, Heger A, Lappe M, et al.(2001) A fully automatic evolutionary classification of protein folds: Dali Domain Dictionary version 3. Nucleic Acids Res 29: 55-57.
19. Poirot O, O'Toole E, Notredame C, (2003) Tcoffee@igs: A web server for computing, evaluating and combining multiple sequence alignments. Nucleic Acids Res 31: 3503-3506.
20. Chan SL, Lee MC, Tan KO, Yang LK, Lee AS, et al.(2003) Identification of chelerythrine as an inhibitor of BclXL function. J Biol Chem 278: 20453-20456.
21. Muller S, Feldman MF, Cornelis GR, (2001) The Type III secretion system of Gram-negative bacteria: a potential therapeutic target? Expert Opin Ther Targets 5: 327-339.
22. Mercier KA, Shortridge MD, Powers R, (2009) A multi-step NMR screen for the identification and evaluation of chemical leads for drug discovery. Comb Chem High Throughput Screen 12: 285-295.
23. Mercier KA, Germer K, Powers R, (2006) Design and characterization of a functional library for NMR screening against novel protein targets. Comb Chem High Throughput Screen 9: 515-534.
24. Stark J, Powers R, (2008) Rapid protein-ligand costructures using chemical shift perturbations. J Am Chem Soc 130: 535-545.
25. Shortridge MD, Hage DS, Harbison GS, Powers R, (2008) Estimating protein-ligand binding affinity using high-throughput screening by NMR. J Comb Chem 10: 948-958.
26. Kubori T, Sukhan A, Aizawa SI, Galan JE, (2000) Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc Natl Acad Sci U S A97: 10225-10230.
27. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, et al.(1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19: 1639-1662.
28. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, et al.(2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681.
29. Holm L, Park J, (2000) DaliLite workbench for protein structure comparison. Bioinformatics 16: 566-567.
30. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al.(1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
31. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al.(2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
32. Rost B, (1999) Twilight zone of protein sequence alignments. Protein Eng 12: 85-94.
33. Bystroff C, Krogh A, (2008) Hidden Markov Models for prediction of protein features. Methods Mol Biol 413: 173-198.
34. Armougom F, Moretti S, Poirot O, Audic S, Dumas P, et al.(2006) Expresso: automatic incorporation of structural information in multiple sequence alignments using 3D-Coffee. 34: W604-W608.
35. Notredame C, Abergel C, (2003) Using multiple alignment methods to assess the quality of genomic data analysis. In: Andrade MA, editors. Bioinformatics and genomes: current perspectives Wymondham (United Kingdom) Horizon Scientific Press.
36. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK, (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35: D198-201.
37. Zhang YH, Bhunia A, Wan KF, Lee MC, Chan SL, et al.(2006) Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft. J Mol Biol 364: 536-549.
38. Xie L, Li J, Bourne PE, (2009) Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol 5: e1000387.
39. Chao DT, Korsmeyer SJ, (1998) BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419.
40. Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G, (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96: 615-624.
41. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D, (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96: 625-634.
42. Suzuki M, Youle RJ, Tjandra N, (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645-654.
43. Vander Heiden MG, Thompson CB, (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: E209-216.
44. Yan L, Miao Q, Sun Y, Yang F, (2003) tBid forms a pore in the liposome membrane. FEBS Lett 555: 545-550.
45. Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, et al.(2005) Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. Embo J 24: 2096-2103.
46. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, et al.(2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342.
47. Breckenridge DG, Xue D, (2004) Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 16: 647-652.
48. Fletcher JI, Meusburger S, Hawkins CJ, Riglar DT, Lee EF, et al.(2008) Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc Natl Acad Sci U S A105:: 18081-18087, S18081/18081-S18081/18087.
49. Kang MH, Reynolds CP, (2009) Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy. Clin Cancer Res 15: 1126-1132.
50. Billen LP, Kokoski CL, Lovell JF, Leber B, Andrews DW, (2008) Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol 6: 1268-1280.
51. Wendt MD, (2008) Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein-protein interaction. Expert Opin Drug Discovery 3: 1123-1143.
52. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al.(1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341.
53. Jiang H, Blouin C, (2007) Insertions and the emergence of novel protein structure: a structure-based phylogenetic study of insertions. BMC Bioinformatics 8: 444.
54. Morett E, Bork P, (1998) Evolution of new protein function: recombinational enhancer Fis originated by horizontal gene transfer from the transcriptional regulator NtrC. FEBS Lett 433: 108-112.
55. Aouacheria A, Brunet F, Gouy M, (2005) Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol 22: 2395-2416.
56. Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT, et al.(2002) The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet 11: 675-687.
57. Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, et al.(1998) Regulated targeting of BAX to mitochondria. J Cell Biol 143: 207-215.
58. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, et al.(1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901.
59. Er E, Lalier L, Cartron PF, Oliver L, Vallette FM, (2007) Control of Bax homodimerization by its carboxyl terminus. J Biol Chem 282: 24938-24947.
60. Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, et al.(2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12: 887-896.
61. Marlovits TC, Kubori T, Lara-Tejero M, Thomas D, Unger VM, et al.(2006) Assembly of the inner rod determines needle length in the type III secretion injectisome. Nature 441: 637-640.
62. Liu R, Ochman H, (2007) Stepwise formation of the bacterial flagellar system. Proc Natl Acad Sci U S A104: 7116-7121.
63. Gophna U, Ron EZ, Graur D, (2003) Bacterial type III secretion systems are ancient and evolved by multiple horizontal-transfer events. Gene 312: 151-163.
64. Rosinski JA, Atchley WR, (1999) Molecular evolution of helix-turn-helix proteins. J Mol Evol 49: 301-309.
65. Kannan N, Neuwald AF, (2005) Did Protein Kinase Regulatory Mechanisms Evolve Through Elaboration of a Simple Structural Component? J Mol Biol 351: 956-972.
66. Shapiro R, (2006) Small molecule interactions were central to the origin of life. Q Rev Biol 81: 105-125.
67. McCann HC, Guttman DS, (2008) Evolution of the type III secretion system and its effectors in plant-microbe interactions. New Phytol 177: 33-47.
68. Gophna U, Ron EZ, Graur D, (2003) Bacterial type III secretion systems are ancient and evolved by multiple horizontal-transfer events. Gene 312: 151-163.
69. Gray MW, Burger G, Lang BF, (2001) The origin and early evolution of mitochondria. GenomeBiology [online computer file] 2: No pp given.
70. Koonin EV, Aravind L, (2002) Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Growth Differ 9: 394-404.
71. Gauthier A, Thomas NA, Finlay BB, (2003) Bacterial Injection Machines. J Biol Chem 278: 25273-25276.
72. Batut J, Andersson SGE, O'Callaghan D, (2004) The evolution of chronic infection strategies in the a-proteobacteria. Nat Rev Microbiol 2: 933-945.
73. Pallen Mark J, Bailey Christopher M, Beatson Scott A, (2006) Evolutionary links between FliH/YscL-like proteins from bacterial type III secretion systems and second-stalk components of the FoF1 and vacuolar ATPases. Protein Sci 15: 935-941.
74. Mulkidjanian AY, Makarova KS, Galperin MY, Koonin EV, (2007) Inventing the dynamo machine: the evolution of the F-type and V-type ATPases. Nat Rev Microbiol 5: 892-899.
75. Koonin EV, Aravind L, (2002) Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ 9: 394-404.
76. Henikoff S, Henikoff JG, (1992) Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A89: 10915-10919.
77. Henikoff S, Henikoff JG, (1993) Performance evaluation of amino acid substitution matrices. Proteins 17: 49-61.
78. Humphrey W, Dalke A, Schulten K, (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-38.
79. Nicholls A, Honig B, (1991) A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Boltzmann equation. J Comput Chem 12: 435-445.
80. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al.(2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.